Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
Lok Bahadur Shrestha, Charles S. P. Foster, William D. Rawlinson, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 406

Showing 1-25 of 406 citing articles:

CRISPR-Cas13a-powered electrochemical biosensor for the detection of the L452R mutation in clinical samples of SARS-CoV-2 variants
Zhi Chen, Chenshuo Wu, Yuxuan Yuan, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 129
Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses
David M. Morens, Jeffery K. Taubenberger, Anthony S. Fauci
Cell Host & Microbe (2023) Vol. 31, Iss. 1, pp. 146-157
Open Access | Times Cited: 126
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 71
Insights for COVID-19 in 2023
Francisco Javier Martín‐Sánchez, Manuel Martı́nez-Sellés, José Molero, et al.
Revista Española de Quimioterapia (2022) Vol. 36, Iss. 2, pp. 114-124
Open Access | Times Cited: 69
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature
Helena C. Maltezou, Amalia Papanikolopoulou, Sofia Vassiliu, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 865-865
Open Access | Times Cited: 44
An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 40
Primary assessment of the diversity of Omicron sublineages and the epidemiologic features of autumn/winter 2022 COVID-19 wave in Chinese mainland
Gang Lü, Yun Ling, Minghao Jiang, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 4, pp. 758-767
Open Access | Times Cited: 40
Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 20
Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion
Song Xue, Yuru Han, Fan Wu, et al.
Protein & Cell (2024) Vol. 15, Iss. 6, pp. 403-418
Open Access | Times Cited: 18
Case fatality rates of COVID‐19 during epidemic periods of variants of concern: A meta-analysis by continents
Qianhang Xia, Yujie Yang, Fengling Wang, et al.
International Journal of Infectious Diseases (2024) Vol. 141, pp. 106950-106950
Open Access | Times Cited: 14
Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave
Yeonju La, Won Sup Oh, Changhyup Kim, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
SARS-CoV-2 evolved variants optimize binding to cellular glycocalyx
Sang Hoon Kim, Fiona L. Kearns, Mia A. Rosenfeld, et al.
Cell Reports Physical Science (2023) Vol. 4, Iss. 4, pp. 101346-101346
Open Access | Times Cited: 35
Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study
Celine Y. Tan, Calvin J. Chiew, Deanette Pang, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 12, pp. 1343-1348
Open Access | Times Cited: 33
Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults — United States, November 1–December 10, 2022
Alyssa Hannah Sinclair, Morgan Taylor, Joshua S. Weitz, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 3, pp. 73-75
Open Access | Times Cited: 32
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 160-160
Open Access | Times Cited: 28
Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic
Luis Daniel González-Vázquez, Miguel Arenas
Genes (2023) Vol. 14, Iss. 2, pp. 407-407
Open Access | Times Cited: 27
Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method
Pavlo Petakh, Nazarii Kobyliak, Oleksandr Kamyshnyi
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 26
Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada
Madeleine W. Sumner, Jianling Xie, Roger Zemek, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e232328-e232328
Open Access | Times Cited: 26
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster
Xun Wang, Shujun Jiang, Wentai Ma, et al.
Cell Host & Microbe (2023) Vol. 32, Iss. 1, pp. 25-34.e5
Open Access | Times Cited: 26
Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses
Chang Yi Wang, Wen‐Jiun Peng, Be-Sheng Kuo, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1010870-e1010870
Open Access | Times Cited: 24
SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype
Seung Bum Park, Mohsin Khan, Sai Chaitanya Chiliveri, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 24
The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review
Aparajita Sarkar, Sara Omar, Aya Alshareef, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top